FPTW
GSK icon

Franklin, Parlapiano, Turner & Welch’s GSK GSK Stock Holding History

Franklin, Parlapiano, Turner & Welch’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-28
Closed -$1.38K – 141
2016
Q3 		$2K Buy
+28
New +$1.53K ﹤0.01% 130

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin, Parlapiano, Turner & Welch's GSK Position: Q4 2016 in Review

Franklin, Parlapiano, Turner & Welch sold out of GSK (GSK) in Q4 2016, closing a stake of 28 shares — an estimated $1.38K sold.

Franklin, Parlapiano, Turner & Welch first reported a position in GSK in Q3 2016 and held it in 1 quarter. The position peaked at $2K in Q3 2016. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • Franklin, Parlapiano, Turner & Welch reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
  • Franklin, Parlapiano, Turner & Welch sold 28 GSK shares in Q4 2016, an estimated $1.38K.
  • Franklin, Parlapiano, Turner & Welch first reported a position in GSK in Q3 2016 and held it in 1 quarter.
  • Franklin, Parlapiano, Turner & Welch's GSK position peaked at $2K in Q3 2016.
  • 762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Franklin, Parlapiano, Turner & Welch's 13F filing for Q4 2016, filed 31 May 2017.